160 related articles for article (PubMed ID: 31670914)
1. Correlation of miR-181a and three HOXA genes as useful biomarkers in acute myeloid leukemia.
Xu P; Zhou D; Yan G; Ouyang J; Chen B
Int J Lab Hematol; 2020 Feb; 42(1):16-22. PubMed ID: 31670914
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML.
Li Z; Huang H; Li Y; Jiang X; Chen P; Arnovitz S; Radmacher MD; Maharry K; Elkahloun A; Yang X; He C; He M; Zhang Z; Dohner K; Neilly MB; Price C; Lussier YA; Zhang Y; Larson RA; Le Beau MM; Caligiuri MA; Bullinger L; Valk PJ; Delwel R; Lowenberg B; Liu PP; Marcucci G; Bloomfield CD; Rowley JD; Chen J
Blood; 2012 Mar; 119(10):2314-24. PubMed ID: 22251480
[TBL] [Abstract][Full Text] [Related]
3. Serum level of miR-10-5p as a prognostic biomarker for acute myeloid leukemia.
Zhi Y; Xie X; Wang R; Wang B; Gu W; Ling Y; Dong W; Zhi F; Liu Y
Int J Hematol; 2015 Sep; 102(3):296-303. PubMed ID: 26134365
[TBL] [Abstract][Full Text] [Related]
4. High serum extracellular vesicle miR-10b expression predicts poor prognosis in patients with acute myeloid leukemia.
Fang Z; Wang X; Wu J; Xiao R; Liu J
Cancer Biomark; 2020; 27(1):1-9. PubMed ID: 31594209
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of serum MicroRNA-203 in patients with acute myeloid leukemia.
Guo Y
Bioengineered; 2019 Dec; 10(1):345-352. PubMed ID: 31411110
[TBL] [Abstract][Full Text] [Related]
6. MN1, FOXP1 and hsa-miR-181a-5p as prognostic markers in acute myeloid leukemia patients treated with intensive induction chemotherapy and autologous stem cell transplantation.
Seipel K; Messerli C; Wiedemann G; Bacher U; Pabst T
Leuk Res; 2020 Feb; 89():106296. PubMed ID: 31927137
[TBL] [Abstract][Full Text] [Related]
7. Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia.
Hickey CJ; Schwind S; Radomska HS; Dorrance AM; Santhanam R; Mishra A; Wu YZ; Alachkar H; Maharry K; Nicolet D; Mrózek K; Walker A; Eiring AM; Whitman SP; Becker H; Perrotti D; Wu LC; Zhao X; Fehniger TA; Vij R; Byrd JC; Blum W; Lee LJ; Caligiuri MA; Bloomfield CD; Garzon R; Marcucci G
Blood; 2013 Jan; 121(1):159-69. PubMed ID: 23100311
[TBL] [Abstract][Full Text] [Related]
8. Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia.
Huang Y; Zou Y; Lin L; Ma X; Chen H
Cancer Biomark; 2018; 22(4):799-805. PubMed ID: 29945348
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of Long Noncoding RNA HOXA-AS2 Suppresses Chemoresistance of Acute Myeloid Leukemia via the miR-520c-3p/S100A4 Axis.
Dong X; Fang Z; Yu M; Zhang L; Xiao R; Li X; Pan G; Liu J
Cell Physiol Biochem; 2018; 51(2):886-896. PubMed ID: 30466095
[TBL] [Abstract][Full Text] [Related]
10. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
[TBL] [Abstract][Full Text] [Related]
11. Transcription factor AP-2α regulates acute myeloid leukemia cell proliferation by influencing Hoxa gene expression.
Ding X; Yang Z; Zhou F; Wang F; Li X; Chen C; Li X; Hu X; Xiang S; Zhang J
Int J Biochem Cell Biol; 2013 Aug; 45(8):1647-56. PubMed ID: 23660297
[TBL] [Abstract][Full Text] [Related]
12. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia.
Lin X; Wang Z; Wang Y; Feng W
Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789
[TBL] [Abstract][Full Text] [Related]
13. Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemia.
Tian C; Zhang L; Li X; Zhang Y; Li J; Chen L
Cancer Biomark; 2018; 22(2):209-215. PubMed ID: 29689705
[TBL] [Abstract][Full Text] [Related]
14. Low miR-34c expression is associated with poor outcome in de novo acute myeloid leukemia.
Yang DQ; Zhou JD; Wang YX; Deng ZQ; Yang J; Yao DM; Qian Z; Yang L; Lin J; Qian J
Int J Lab Hematol; 2017 Feb; 39(1):42-50. PubMed ID: 27577964
[TBL] [Abstract][Full Text] [Related]
15. Low Expression of FUS1 Is Negatively Correlated with miR-378 and May Predict Adverse Prognoses in Acute Myeloid Leukemia.
Tang X; Zhou J; Zhang J; Zhou LY; Zhai LL; Vanessa ME; Yi J; Yi YY; Lin J; Deng ZQ
Acta Haematol; 2018; 139(2):89-95. PubMed ID: 29393096
[TBL] [Abstract][Full Text] [Related]
16. Identification of circulating microRNAs as potential biomarkers for detecting acute myeloid leukemia.
Zhi F; Cao X; Xie X; Wang B; Dong W; Gu W; Ling Y; Wang R; Yang Y; Liu Y
PLoS One; 2013; 8(2):e56718. PubMed ID: 23437222
[TBL] [Abstract][Full Text] [Related]
17. The clinical characteristics and prognostic significance of MN1 gene and MN1-associated microRNA expression in adult patients with de novo acute myeloid leukemia.
Xiang L; Li M; Liu Y; Cen J; Chen Z; Zhen X; Xie X; Cao X; Gu W
Ann Hematol; 2013 Aug; 92(8):1063-9. PubMed ID: 23515710
[TBL] [Abstract][Full Text] [Related]
18. Serum miR-22 is a novel prognostic marker for acute myeloid leukemia.
Qu H; Zheng G; Cheng S; Xie W; Liu X; Tao Y; Xie B
J Clin Lab Anal; 2020 Sep; 34(9):e23370. PubMed ID: 32533562
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the Diagnostic Potential of miR-29a-3p and miR-92a-3p as Circulatory Biomarkers in Acute Myeloid Leukemia.
Gado MM; Mousa NO; Badawy MA; El Taweel MA; Osman A
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3625-3633. PubMed ID: 31870103
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of miR-210 is Associated with Poor Prognosis of Acute Myeloid Leukemia.
Tang X; Chen L; Yan X; Li Y; Xiong Y; Zhou X
Med Sci Monit; 2015 Nov; 21():3427-33. PubMed ID: 26549593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
